NewtekOne Q1 EPS $0.46 beats forecast $0.41; reaffirms FY2023 EPS $1.70-$2.00

NewtekOne, Inc.

2023-FY EPS reported $0.46

Net income $11.7M, $0.46 per basic share, vs forecast $0.41.
Reiterated FY2023 EPS forecast of $1.70-$2.00; Q1 $0.46 on track.
First quarterly dividend as financial holding company: $0.18/share paid April 14, above forecast $0.16.
Newtek Bank deposits $224.7M at March 31, grew to ~$310M by April 28 (121% from Dec 2022).
Total commercial loan closings $228.9M in Q1, up 12.5% YoY.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

NewtekOne, Inc. reported three months ended March 31, 2023 results: net income Net Income was $11.7 million, EPS $0.46 per basic common share.

Period: three months ended March 31, 2023
Net income: Net Income was $11.7 million
EPS: $0.46 per basic common share
Result: reported results

Exact text from the filing

Net Income was $11.7 million, or $0.46 per basic common share, for the three months ended March 31, 2023, which exceeded its previously stated forecast of $0.41 per basic common share.

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

NewtekOne, Inc. reported Full Year 2023 results: EPS $1.70 to $2.00 of earnings per share. Guidance reaffirmed.

Period: Full Year 2023
EPS: $1.70 to $2.00 of earnings per share
Guidance: reaffirmed
Result: guidance update

Exact text from the filing

The Company is reiterating previously issued earnings forecast for the full year 2023 in a range of $1.70 to $2.00 of earnings per share.

View on SEC.gov

8 earnings releases filed in the last 30 days. Browse all earnings releases →

NewtekOne, Inc. filing history →

Source: SEC EDGAR

accession 0001587987-23-000103

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.